MD
MEDNAX Inc
Price:  
7.36 
USD
Volume:  
1,730,200.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MD EV/EBITDA

55.2%
Upside

As of 2024-05-30, the EV/EBITDA ratio of MEDNAX Inc (MD) is 6.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MD's latest enterprise value is 1,321.10 mil USD. MD's TTM EBITDA according to its financial statements is 189.71 mil USD. Dividing these 2 quantities gives us the above MD EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.3x - 17.4x 16.0x
Forward P/E multiples 14.6x - 16.1x 15.5x
Fair Price (5.19) - 30.98 11.42
Upside -170.5% - 320.9% 55.2%
7.36 USD
Stock Price
11.42 USD
Fair Price

MD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-30 6.96
2024-05-29 6.92
2024-05-28 6.94
2024-05-24 7.01
2024-05-23 7.07
2024-05-22 7.04
2024-05-21 6.96
2024-05-20 7.01
2024-05-17 7.13
2024-05-16 7.15
2024-05-15 7.34
2024-05-14 7.46
2024-05-13 7.48
2024-05-10 7.35
2024-05-09 7.32
2024-05-08 7.47
2024-05-07 7.71
2024-05-06 7.82
2024-05-03 7.84
2024-05-02 7.74
2024-05-01 7.70
2024-04-30 7.63
2024-04-29 7.70
2024-04-26 7.71
2024-04-25 7.65
2024-04-24 7.80
2024-04-23 7.87
2024-04-22 7.70
2024-04-19 7.70
2024-04-18 7.61
2024-04-17 7.61
2024-04-16 7.66
2024-04-15 7.77
2024-04-12 7.80
2024-04-11 7.87
2024-04-10 7.95
2024-04-09 7.94
2024-04-08 7.92
2024-04-05 7.86
2024-04-04 7.79
2024-04-03 7.83
2024-04-02 7.91
2024-04-01 8.02
2024-03-28 8.15
2024-03-27 8.13
2024-03-26 7.95
2024-03-25 7.82
2024-03-22 7.83
2024-03-21 7.85
2024-03-20 7.96